Meeting Banner
Abstract #4529

Evaluation of Biochemically Recurrent Prostate Cancer Using the Prostate Imaging for Recurrence Reporting Systems

xiang liu1, Jun Shen2, and Kan Deng3
1department of radiology, Sun Yat-Sen Memorial Hospital, Guangzhou, China, 2Sun Yat-Sen Memorial Hospital, Guangzhou, China, 3Philips Healthcare, Guangzhou, China

Synopsis

Keywords: Preclinical Image Analysis, Preclinical, Prostate Imaging for Recurrence Reporting; Prostate cancer; Recurrence; Interreader agreement.

Motivation: PI-RR assessment is not universally validated and has not yet been extensively studied for diagnostic accuracy and interreader variability.

Goal(s): To evaluate the performance of PI-RR for detecting local recurrence in PCa patients with BCR after radiation therapy (RT) or radical prostatectomy (RP).

Approach: 110 patients who underwent MRI and FDG PET/CT were included. A group of four radiologists with varying experience was recruited for recurrence evaluation.

Results: With a PI-RR of 3 as a cutoff, the AUCs ranged from 0.56 to 0.83 after RT and 0.73 to 0.90 after RP across the four readers. The ICC values were 0.54 and 0.68, respectively.

Impact: PI-RR may serve as a clinical guide to improve the management of recurrent PCa by achieving good diagnostic performance and interreader agreement.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords